Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Ludeman
Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer
PLoS ONE
Multidisciplinary
Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer
PLoS ONE
Multidisciplinary
Structure-Function Analysis of Tetraspanin CD151
CD151—A Striking Marker for Cancer Therapy
Biomarkers in Cancer
Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis
Journal of Cancer
Oncology
Tetraspanin CD151 Plays a Key Role in Skin Squamous Cell Carcinoma
Oncogene
Cancer Research
Genetics
Molecular Biology